Incidence, Prevalence, and Survival of Prostate Cancer in the UK.

ABSTRACT:

Importance

Incidence, prevalence, and survival are pertinent measures to inform the management and provision of prostate cancer care.

Objective

To calculate the incidence, prevalence, and survival rates for prostate cancer in the UK from 2000 to 2021.

Design, setting, and participants

This population-based cohort study uses routinely collected primary care data from the UK. Male patients aged 18 years or older with at least 1 year of history registered in Clinical Practice Research Datalink (CPRD) GOLD or Aurum were included. Data were analyzed from January 2023 to March 2024.

Main outcomes and measures

Prostate cancer incidence rates (IR), period prevalence (PP), and 1-, 5-, and 10-year survival after diagnosis between 2000 and 2021, stratified by age and cale

SUBMITTER: Tan EH 

PROVIDER: S-EPMC12315704 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature